A citation-based method for searching scientific literature

Jens Juul Holst. Physiol Rev 2007
Times Cited: 1829







List of co-cited articles
640 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Biology of incretins: GLP-1 and GIP.
Laurie L Baggio, Daniel J Drucker. Gastroenterology 2007
13

Glucagon-like peptide-1 7-36: a physiological incretin in man.
B Kreymann, G Williams, M A Ghatei, S R Bloom. Lancet 1987
10

Glucagon-like peptide 1 (GLP-1).
T D Müller, B Finan, S R Bloom, D D'Alessio, D J Drucker, P R Flatt, A Fritsche, F Gribble, H J Grill, J F Habener,[...]. Mol Metab 2019
229
10

Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes.
Steven P Marso, Stephen C Bain, Agostino Consoli, Freddy G Eliaschewitz, Esteban Jódar, Lawrence A Leiter, Ildiko Lingvay, Julio Rosenstock, Jochen Seufert, Mark L Warren,[...]. N Engl J Med 2016
9

Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.
Steven P Marso, Gilbert H Daniels, Kirstine Brown-Frandsen, Peter Kristensen, Johannes F E Mann, Michael A Nauck, Steven E Nissen, Stuart Pocock, Neil R Poulter, Lasse S Ravn,[...]. N Engl J Med 2016
9

The arcuate nucleus mediates GLP-1 receptor agonist liraglutide-dependent weight loss.
Anna Secher, Jacob Jelsing, Arian F Baquero, Jacob Hecksher-Sørensen, Michael A Cowley, Louise S Dalbøge, Gitte Hansen, Kevin L Grove, Charles Pyke, Kirsten Raun,[...]. J Clin Invest 2014
371
8


Gut hormone profiles following bariatric surgery favor an anorectic state, facilitate weight loss, and improve metabolic parameters.
Carel W le Roux, Simon J B Aylwin, Rachel L Batterham, Cynthia M Borg, Frances Coyle, Vyas Prasad, Sandra Shurey, Mohammad A Ghatei, Ameet G Patel, Stephen R Bloom. Ann Surg 2006
672
7

Glucagon-like peptide-1 cells in the gastrointestinal tract and pancreas of rat, pig and man.
R Eissele, R Göke, S Willemer, H P Harthus, H Vermeer, R Arnold, B Göke. Eur J Clin Invest 1992
449
7

The Discovery and Development of Liraglutide and Semaglutide.
Lotte Bjerre Knudsen, Jesper Lau. Front Endocrinol (Lausanne) 2019
106
7

Molecular mechanisms of glucose-stimulated GLP-1 secretion from perfused rat small intestine.
Rune E Kuhre, Charlotte R Frost, Berit Svendsen, Jens J Holst. Diabetes 2015
95
7

Glucagon-like peptide 1 promotes satiety and suppresses energy intake in humans.
A Flint, A Raben, A Astrup, J J Holst. J Clin Invest 1998
926
6

A role for glucagon-like peptide-1 in the central regulation of feeding.
M D Turton, D O'Shea, I Gunn, S A Beak, C M Edwards, K Meeran, S J Choi, G M Taylor, M M Heath, P D Lambert,[...]. Nature 1996
6


Inhibition of food intake in obese subjects by peptide YY3-36.
Rachel L Batterham, Mark A Cohen, Sandra M Ellis, Carel W Le Roux, Dominic J Withers, Gary S Frost, Mohammad A Ghatei, Stephen R Bloom. N Engl J Med 2003
6

A Randomized, Controlled Trial of Liraglutide for Adolescents with Obesity.
Aaron S Kelly, Pernille Auerbach, Margarita Barrientos-Perez, Inge Gies, Paula M Hale, Claude Marcus, Lucy D Mastrandrea, Nandana Prabhu, Silva Arslanian. N Engl J Med 2020
68
8

Short-chain fatty acids stimulate glucagon-like peptide-1 secretion via the G-protein-coupled receptor FFAR2.
Gwen Tolhurst, Helen Heffron, Yu Shan Lam, Helen E Parker, Abdella M Habib, Eleftheria Diakogiannaki, Jennifer Cameron, Johannes Grosse, Frank Reimann, Fiona M Gribble. Diabetes 2012
977
5

Comparison of Human and Murine Enteroendocrine Cells by Transcriptomic and Peptidomic Profiling.
Geoffrey P Roberts, Pierre Larraufie, Paul Richards, Richard G Kay, Sam G Galvin, Emily L Miedzybrodzka, Andrew Leiter, H Joyce Li, Leslie L Glass, Marcella K L Ma,[...]. Diabetes 2019
50
10

Central administration of GLP-1-(7-36) amide inhibits food and water intake in rats.
M Tang-Christensen, P J Larsen, R Göke, A Fink-Jensen, D S Jessop, M Møller, S P Sheikh. Am J Physiol 1996
447
5


Glucagon-Like Peptide-1 Receptor Activation in the Ventral Tegmental Area Decreases the Reinforcing Efficacy of Cocaine.
Heath D Schmidt, Elizabeth G Mietlicki-Baase, Kelsey Y Ige, John J Maurer, David J Reiner, Derek J Zimmer, Duncan S Van Nest, Leonardo A Guercio, Mathieu E Wimmer, Diana R Olivos,[...]. Neuropsychopharmacology 2016
65
7


A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans.
D E Cummings, J Q Purnell, R S Frayo, K Schmidova, B E Wisse, D S Weigle. Diabetes 2001
5

Bile Acids Trigger GLP-1 Release Predominantly by Accessing Basolaterally Located G Protein-Coupled Bile Acid Receptors.
Cheryl A Brighton, Juraj Rievaj, Rune E Kuhre, Leslie L Glass, Kristina Schoonjans, Jens J Holst, Fiona M Gribble, Frank Reimann. Endocrinology 2015
162
5

Ghrelin, CCK, GLP-1, and PYY(3-36): Secretory Controls and Physiological Roles in Eating and Glycemia in Health, Obesity, and After RYGB.
Robert E Steinert, Christine Feinle-Bisset, Lori Asarian, Michael Horowitz, Christoph Beglinger, Nori Geary. Physiol Rev 2017
217
5

Gut hormone PYY(3-36) physiologically inhibits food intake.
Rachel L Batterham, Michael A Cowley, Caroline J Small, Herbert Herzog, Mark A Cohen, Catherine L Dakin, Alison M Wren, Audrey E Brynes, Malcolm J Low, Mohammad A Ghatei,[...]. Nature 2002
5

Classification and functions of enteroendocrine cells of the lower gastrointestinal tract.
Ashok R Gunawardene, Bernard M Corfe, Carolyn A Staton. Int J Exp Pathol 2011
136
5

Enteroendocrine cells: a site of 'taste' in gastrointestinal chemosensing.
Catia Sternini, Laura Anselmi, Enrique Rozengurt. Curr Opin Endocrinol Diabetes Obes 2008
228
5

Efficacy and safety of LY3298176, a novel dual GIP and GLP-1 receptor agonist, in patients with type 2 diabetes: a randomised, placebo-controlled and active comparator-controlled phase 2 trial.
Juan Pablo Frias, Michael A Nauck, Joanna Van, Mark E Kutner, Xuewei Cui, Charles Benson, Shweta Urva, Ruth E Gimeno, Zvonko Milicevic, Deborah Robins,[...]. Lancet 2018
237
5

Exaggerated glucagon-like peptide 1 response is important for improved β-cell function and glucose tolerance after Roux-en-Y gastric bypass in patients with type 2 diabetes.
Nils B Jørgensen, Carsten Dirksen, Kirstine N Bojsen-Møller, Siv H Jacobsen, Dorte Worm, Dorte L Hansen, Viggo B Kristiansen, Lars Naver, Sten Madsbad, Jens J Holst. Diabetes 2013
192
5

Acute and long-term effects of Roux-en-Y gastric bypass on glucose metabolism in subjects with Type 2 diabetes and normal glucose tolerance.
N B Jørgensen, S H Jacobsen, C Dirksen, K N Bojsen-Møller, L Naver, L Hvolris, T R Clausen, B S Wulff, D Worm, D Lindqvist Hansen,[...]. Am J Physiol Endocrinol Metab 2012
208
5

Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013.
Marie Ng, Tom Fleming, Margaret Robinson, Blake Thomson, Nicholas Graetz, Christopher Margono, Erin C Mullany, Stan Biryukov, Cristiana Abbafati, Semaw Ferede Abera,[...]. Lancet 2014
5

Efficacy and safety of semaglutide compared with liraglutide and placebo for weight loss in patients with obesity: a randomised, double-blind, placebo and active controlled, dose-ranging, phase 2 trial.
Patrick M O'Neil, Andreas L Birkenfeld, Barbara McGowan, Ofri Mosenzon, Sue D Pedersen, Sean Wharton, Charlotte Giwercman Carson, Cecilie Heerdegen Jepsen, Maria Kabisch, John P H Wilding. Lancet 2018
179
5

Once-Weekly Semaglutide in Adults with Overweight or Obesity.
John P H Wilding, Rachel L Batterham, Salvatore Calanna, Melanie Davies, Luc F Van Gaal, Ildiko Lingvay, Barbara M McGowan, Julio Rosenstock, Marie T D Tran, Thomas A Wadden,[...]. N Engl J Med 2021
133
5


GLP-1 and weight loss: unraveling the diverse neural circuitry.
Scott E Kanoski, Matthew R Hayes, Karolina P Skibicka. Am J Physiol Regul Integr Comp Physiol 2016
89
5

A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management.
Xavier Pi-Sunyer, Arne Astrup, Ken Fujioka, Frank Greenway, Alfredo Halpern, Michel Krempf, David C W Lau, Carel W le Roux, Rafael Violante Ortiz, Christine Bjørn Jensen,[...]. N Engl J Med 2015
715
5

Glucagon-like Peptide-1 receptor agonists activate rodent thyroid C-cells causing calcitonin release and C-cell proliferation.
Lotte Bjerre Knudsen, Lars Wichmann Madsen, Søren Andersen, Kasper Almholt, Anne S de Boer, Daniel J Drucker, Carsten Gotfredsen, Frederikke Lihme Egerod, Anne Charlotte Hegelund, Helene Jacobsen,[...]. Endocrinology 2010
341
5

G-protein-coupled receptors in intestinal chemosensation.
Frank Reimann, Gwen Tolhurst, Fiona M Gribble. Cell Metab 2012
153
4








The expression of GLP-1 receptor mRNA and protein allows the effect of GLP-1 on glucose metabolism in the human hypothalamus and brainstem.
Elvira Alvarez, M Dolores Martínez, Isabel Roncero, Julie A Chowen, Beatriz García-Cuartero, Juan D Gispert, Carmen Sanz, Patricia Vázquez, Antonio Maldonado, Javier de Cáceres,[...]. J Neurochem 2005
162
4

Functional interactions between the gut microbiota and host metabolism.
Valentina Tremaroli, Fredrik Bäckhed. Nature 2012
4

An obesity-associated gut microbiome with increased capacity for energy harvest.
Peter J Turnbaugh, Ruth E Ley, Michael A Mahowald, Vincent Magrini, Elaine R Mardis, Jeffrey I Gordon. Nature 2006
4

Potent derivatives of glucagon-like peptide-1 with pharmacokinetic properties suitable for once daily administration.
L B Knudsen, P F Nielsen, P O Huusfeldt, N L Johansen, K Madsen, F Z Pedersen, H Thøgersen, M Wilken, H Agersø. J Med Chem 2000
448
4


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.